Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Oncogene ; 25(49): 6489-96, 2006 Oct 19.
Article in English | MEDLINE | ID: mdl-16702949

ABSTRACT

Identifying versatile inhibitors of metastasis that operate in multiple sites against distinct cancer cell types is important for designing novel therapeutics for metastasis. We show that multiple tissues of timp-3-/- mice are more susceptible to metastatic colonization. Overall, a 5-14-fold increase in liver and kidney colonization occurred by EL-4 lymphoma cells, and a twofold increase upon targeting B16F10 melanoma cells to the bone or lung of timp-3-/- mice. There was a general lack of macrophage or neutrophil localization to metastases in the liver, kidney and lung, and of osteoclasts to bone in both genotypes. Analysis of lung showed that proliferation or angiogenesis were unaltered within the metastatic colonies. Lung-trap assays revealed that initial tumor cell trapping was similar in the lung vasculature of timp-3-/- and wild-type mice. However, more tumor cells were found in timp-3-/- lungs at 48 and 96 h after tumor cell injection indicating more efficient extravasation and initial proliferation. Activation of pro-MMP-2 was greater in timp-3-/- lungs at these time points. These data demonstrate TIMP-3 functions to inhibit metastatic dissemination of diverse cancer cells to multiple organs. TIMP-3 regulates MMP-2 activation to limit tumor cell extravasation and subsequent colonization of the lung, without augmenting inflammatory cell response.


Subject(s)
Lymphoma/pathology , Melanoma, Experimental/secondary , Neoplasm Metastasis/genetics , Tissue Inhibitor of Metalloproteinase-3/genetics , Animals , Cell Proliferation , Genetic Predisposition to Disease , Inflammation/pathology , Kidney/pathology , Kidney Neoplasms/genetics , Kidney Neoplasms/pathology , Lung/metabolism , Lung/pathology , Lung Neoplasms/pathology , Matrix Metalloproteinase 2/metabolism , Melanoma, Experimental/pathology , Mice , Mice, Inbred C57BL , Mice, Transgenic , Neoplasm Invasiveness/pathology , Neovascularization, Pathologic/mortality , Skin Neoplasms/pathology , Skin Neoplasms/secondary
2.
J Clin Invest ; 108(6): 817-29, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11560951

ABSTRACT

Tissue inhibitors of metalloproteinases regulate ECM degradation by matrix metalloproteinases (MMPs). We have developed a mouse line deficient for tissue inhibitor of metalloproteinases-3 (TIMP-3), the only TIMP known to reside within the ECM. Homozygous Timp-3-null animals develop spontaneous air space enlargement in the lung that is evident at 2 weeks after birth and progresses with age of the animal. As early as 13 months of age animals become moribund. Lung function, measured by carbon monoxide uptake, is impaired in aged null animals. Lungs from aged null animals have reduced abundance of collagen, enhanced degradation of collagen in the peribronchiolar space, and disorganization of collagen fibrils in the alveolar interstitium, but no increase in inflammatory cell infiltration or evidence of fibrosis in comparison with controls. Using in situ zymography, we show that lungs from aged null animals have heightened MMP activity over wild-type and heterozygotic animals. Finally, TIMP-3-null fibroblast cultures demonstrate enhanced destruction of ECM molecules in vitro. We propose that the deletion of TIMP-3 results in a shift of the TIMP/MMP balance in the lung to favor ECM degradation, culminating in incapacitating illness and a shorter life span.


Subject(s)
Lung/pathology , Tissue Inhibitor of Metalloproteinase-3/physiology , Air , Animals , Collagen/metabolism , Extracellular Matrix/physiology , Lung/physiopathology , Matrix Metalloproteinases/metabolism , Mice , Mice, Knockout , Pulmonary Alveoli/pathology , Tissue Inhibitor of Metalloproteinase-3/deficiency , Tissue Inhibitor of Metalloproteinase-3/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...